Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × mogamulizumab × Lymphoid × Clear all

Phase

Status

Sponsor Class

INDUSTRY 11 OTHER 8 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 78 Vincristine 71 Doxorubicin 59 Prednisone 55 Cytarabine 51 Methotrexate 49 Rituximab 41 Etoposide 39 Radiotherapy 36 Dexamethasone 36 Filgrastim 35 Granulocyte Colony-Stimulating Factor 24 Mercaptopurine 22 Leucovorin 22 Calcium Dobesilate 19 Daunorubicin 18 pegaspargase 16 Asparaginase 15 merphos 14 Peripheral Blood Stem Cell Transplantation 14 Bleomycin 14 Thioguanine 13 Specimen Handling 13 Vinblastine 11 Ifosfamide 11 Hydrocortisone 11 Gene Expression Profiling 11 Gemcitabine 11 fludarabine phosphate 10 Methylprednisolone 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04128072 2024-04-05

MOGAT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡